Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
about
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesBiomarker development in MET-targeted therapyMolecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentGenetic alterations in hepatocellular carcinoma: An updateSAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.Oncogenic HER2 fusions in gastric cancer.Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma.Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory CircuitAstrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative ResectionGenomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentMineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma.MTDH genetic variants in colorectal cancer patients.Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human diseasePARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.Emerging role of lncRNA in cancer: a potential avenue in molecular medicine.Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsThe Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.Exploration of liver cancer genomes.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.Trends in the development of MET inhibitors for hepatocellular carcinoma.c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion.Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.The functional consequences and prognostic value of dosage sensitivity in ovarian cancer.FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.Circulating Tumor DNA Testing for Liver Cancer.Widespread epistasis regulates glucose homeostasis and gene expressionIncreased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
P2860
Q27555640-47B12F80-5CF1-454D-9314-4B0BAC19AD5FQ54795968-6CBDA768-65E2-4FC7-939B-69F2FF55EF0BQ54795973-5475C6CF-6888-427B-B287-CB072ABDED0FQ54881836-43F6F1E7-6DB8-4AA5-A2CF-D3CB64AA7901Q54882746-DA060EB7-1BD1-4927-82AB-16AFDDD69E86Q54889847-5C6819FA-E050-4613-B771-EE88837F03E2Q54889850-8D198749-033E-4C9B-AA07-51040D28C3FBQ54896843-7246F360-B2D2-4EAA-A2C9-D7D7E960BE60Q54896848-06FEB6B5-B4F9-4C85-BA7D-7D101127C148Q54898639-BBCAC7A2-4105-4E4A-9F42-577CD1ECAB32Q54898640-1A22621C-7494-445B-8C43-6EBC98AF5ADBQ54898641-080BBDD8-6DBC-4B26-9D30-0E7D793F972AQ54898642-B05D2AD5-571A-43FA-8200-11BD498EEF4FQ54898644-8ABB1629-9A4D-4A7D-ABB7-EDF76320DCE2Q54898645-FDFCA6E1-4C94-4D43-9B7E-B66D9E841E25Q54900854-2ED58928-7B7D-4212-8323-3E6D86EDF95BQ54905533-D41A111A-08E1-46F6-A49E-F62A0020D020Q54905534-94AD9492-B186-4C89-8429-3217BFC1198AQ54947574-B06638CD-6FA4-4A09-9DFC-94834D5377B3Q54948823-8D142049-AA92-4C9F-B8F7-D3BE76CF89B8Q54948825-95C10E60-F785-47FE-BC2F-F26692496244Q54953666-D751AB07-C6A0-4F85-970A-6246CF883B9DQ54954976-9CE1FA34-6AC0-421D-BD49-0505A9225BF8Q54955141-893B6A1C-57C2-460E-8C86-4516F63CBA6AQ54955183-F2C5F4F7-DBEE-4E9D-BE52-A4B19F589098Q54955184-62D905F2-F07A-4D10-8FFC-0DA217A66F10Q54955197-48978F44-57AD-44CF-9C82-A8BCA71CD82DQ54955201-B7194D64-9922-4595-996E-9BF92CB342DAQ54955204-012C720D-F8B3-43E1-A16B-1F0D32370697Q5731621-C11946D5-22E8-4215-9807-9AF09CDEAC00
P1343
Q26745338-3DF855BE-B0BC-4512-B48D-EBDA6AF08286Q26751332-2F8E4541-5283-4A3F-8890-EED37BF18B17Q26766689-7BB89684-4554-4DAC-8DB5-F396111430FEQ26784218-AADDCE2D-8F01-419D-B579-0A3123279030Q26851211-1C8CBAAE-9222-460F-8197-23A1441A0F79Q28073241-EA4BEE1B-6B8B-405B-AC04-568B83206023Q31026307-B9884A34-FCB4-4D1A-9572-D5144D9269F1Q35414389-B314FD9D-0217-4847-A1CB-D4D47644D718Q35627999-E8807FCA-C28C-4B73-B42F-A0FF80641982Q35855687-801E3775-E2CC-4849-8EF7-A9833EA683E5Q35879670-326ACB0E-C7FD-4028-A66A-8125361BACCAQ36104399-18F039AC-D35E-4932-874D-82084438A5F6Q36169254-3D7A5C9B-9615-4F03-87ED-9F7EE45253BBQ36186943-0397D339-8C5A-4C3B-A0AF-7E2CCD4A442EQ36299617-AD340FF4-1F42-4B1D-BA96-9F764B2CE885Q36584193-4798B618-C411-482B-A73F-5548D3470D7BQ36694223-F3510957-2C1D-4F82-AAC4-3620FA7E012FQ36706884-FC36E670-2721-4A13-AB59-99D7EF0CFD63Q37031827-6D9958DE-2097-4208-AE3E-47BFC25EAE26Q37165955-0E4D9323-FD39-45F4-AD39-358BB06D075FQ37295260-D0160905-A8E2-4C9E-897A-7E064F8625B3Q37408915-4DD2196C-6014-4245-863E-6A95654D1796Q37668563-D3CAA668-CABD-4164-8B5A-0AA0FDC4478BQ37706763-41135BDE-34E2-496D-8983-00CD5F9B0EF3Q38178032-8E2311A3-DDCD-4F12-8A11-187E54DF612FQ38182833-CD3F2904-4F16-48D8-A27D-3C9BFCE99A61Q38209599-EA520A9D-1C7F-4542-A693-14AF21C2AC2AQ38767392-6F5247CE-C8CC-464E-BBCC-1E491B11003DQ38777675-21194C2D-7620-4EC2-B80A-64F51D57E807Q38923535-74A9316E-D7C3-4F43-A1B4-EFF6119C4296Q39174153-4F2CFDC3-4D66-49FD-9655-329BC6A0DF66Q39629883-E610C061-4C6D-4F37-8FB5-BE6E28D4B77AQ40389670-336488A8-058D-43D8-9E3E-51D9B50B0931Q41108851-D66CCB20-4E6E-44C0-9679-52DF1B6C30A4Q41472059-3608A7DF-CB7D-4284-A74E-913248062D84Q42019561-9ADF134B-C7FD-47F5-B40C-F15C9A14DB8AQ42182370-904E0D77-AB72-4594-8BC5-EEC1F900DF71Q42322534-BF324E80-0930-49A9-BB0C-83BF72D35B3AQ42705169-C9592697-DCDC-4016-8D57-50E5E379ABCDQ47266195-DA74B7BA-32CC-4DEC-B9A3-F182AB0279AB
P2860
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@en
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@nl
type
label
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@en
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@nl
prefLabel
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@en
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@nl
P2093
P2860
P4510
P356
P1433
P1476
Genomic landscape of copy numb ...... s in hepatocellular carcinoma.
@en
P2093
Cheol-Keun Park
David Pocalyko
Ho Yeong Lim
Jeeyun Lee
Jiangchun Xu
Paul A Rejto
Shibing Deng
Stephanie Shi
P2860
P304
P356
10.1002/HEP.26402
P407
P577
2013-07-01T00:00:00Z